C07C 281/18
The other nitrogen atom being further doubly-bound to a carbon atom
Official title: the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
C07C281/18 (The other nitrogen atom being further doubly-bound to a carbon atom) appears on 129 US grants and 76 published applications in this corpus.
Search patents in C07C- Granted patents
- 129
- Published applications
- 76
- Assignees
- 73
- Inventors
- 285
- Latest grant
- 11 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 5 | 0 |
| 1978 | 7 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 4 |
| 2002 | 3 | 2 |
| 2003 | 3 | 4 |
| 2004 | 2 | 3 |
| 2005 | 2 | 3 |
| 2006 | 4 | 4 |
| 2007 | 3 | 0 |
| 2008 | 0 | 3 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 2 | 3 |
| 2012 | 1 | 0 |
| 2013 | 2 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 5 |
| 2017 | 4 | 8 |
| 2018 | 1 | 7 |
| 2019 | 6 | 6 |
| 2020 | 8 | 8 |
| 2021 | 5 | 1 |
| 2022 | 3 | 6 |
| 2023 | 2 | 0 |
| 2024 | 1 | 2 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Therapeutic compounds11 Jun 2024US 12,006,294 B2Regents of the University of Minnesota
- Antifungal compounds and methods of forming the same26 Dec 2023US 11,851,391 B2University of Kentucky Research Foundation
- Methods for treating protozoan infections31 Jan 2023US 11,566,012 B2Neoculi Pty Ltd
- Methods for selecting phosphatase selective and non-selective phosphatase inhibitors21 Jun 2022US 11,364,211 B2United Kingdom Research and Innovation
- Inhibitors and their uses24 May 2022US 11,337,941 B2United Kingdom Research and Innovation
- Compositions, methods, and systems for the synthesis and use of imaging agents29 May 2025US 2025/0170282 A1Lantheus Medical Imaging, Inc.
- Self-assembled active agents14 Nov 2024US 2024/0373854 A1
- Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications5 Sep 2024US 2024/0293343 A1Inflectis Bioscience
- Compositions, methods, and systems for the synthesis and use of imaging agents27 Oct 2022US 2022/0339303 A1Lantheus Medical Imaging, Inc.
- Methods for selecting phosphatase selective and non-selective phosphatase inhibitors6 Oct 2022US 2022/0313628 A1United Kingdom Research and Innovation
Most cited
By later US patents
- Guanylhydrazones and their use to treat inflammatory conditions94US 5,854,289 AThe Picower Institute for Medical Research · 1998
- Therapeutic agents47US 4,060,640 AShell Oil Company · 1977
- Therapeutic agents41US 3,975,533 AShell Oil Company · 1976
- 2-alkylidene-aminoguanidines and methods of use therefor41US 5,272,165 AAlteon Inc. · 1993
- Guanylhydrazones and their use to treat inflammatory conditions41US 5,750,573 AThe Picower Institute for Medical Research · 1998